ProCAncer-I at the AIRMM/ISMRM ITALIAN CHAPTER Congress in Pisa

Published on: November 27, 2022
Categories: News

Our partner Prof Emanuele Neri from the University of Pisa (UNIPI) participated at the AIRMM/ISMRM ITALIAN CHAPTER Congress (Associazione Italiana di RM in Medicina / International Society of MR in Medicine) in Pisa (23-25/11/2022). Prof. Neri made a talk entitled “MRI in biobanks” during the “MR in oncology” session, where he discussed some issued also arised by ProCAncer-I project. The event was both in person and virtual, with participation from all over the world.

 

 

 

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Stay in touch!